Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02966470 · ClinicalTrials.gov registry record
Hand Grip Strength as a Marker of Frailty in Surgical Patients
A clinical trial, sponsored by Yale University.
- Terminated
- Registry status
- 52
- Enrollment target
NCT02966470: Clinical Trial study, sponsored by Yale University.
NCT02966470 is a clinical trial that was terminated before completion, run by Yale University. The registered enrollment target is 52 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02966470 was terminated before completion, sponsored by Yale University.
- TERMINATED
- Registry status
- 52 participants
- Enrollment target
Study Summary
This study aims to assess if grip strength can be used as a single, objective surrogate of frailty assessment in the surgical population.
Primary Outcome
Their frailty survey and grip strength scores will also be recorded for analysis. We will analyze the data by linear regression of grip strength to frailty survey score.
Interventions
- DEVICE Obtain grip strength from a standardized gripometer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2018-02-01 |
| Est. Completion | 2019-09-25 |
Why NCT02966470 stopped before completion
NCT02966470 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 52 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Obtain grip strength from a standardized gripometer is the first listed.
NCT02966470 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02966470 about?
NCT02966470 is a clinical study titled "Hand Grip Strength as a Marker of Frailty in Surgical Patients". This study aims to assess if grip strength can be used as a single, objective surrogate of frailty assessment in the surgical population.
What is the current status of trial NCT02966470?
This trial is currently terminated. The enrollment target is 52 participants. The study started on 2018-02-01. Estimated completion is 2019-09-25.
What interventions are being tested in trial NCT02966470?
The interventions under investigation include: Obtain grip strength from a standardized gripometer (DEVICE).
Who is sponsoring clinical trial NCT02966470?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02630121 · 52 participants · Phase 4
Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea
- NCT03629171 · 52 participants · Phase 2
Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia
- NCT04128748 · 52 participants · Phase 1
Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome
- NCT04150497 · 52 participants · Phase 1
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI